Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 28,035
+55 (0.20%)
At close: Dec 19, 2025
Abbott India Market Cap
Abbott India has a market cap or net worth of 595.82 billion as of December 19, 2025. Its market cap has decreased by -0.06% in one year.
Market Cap
595.82B
Enterprise Value
574.22B
Revenue
67.14B
Ranking
n/a
PE Ratio
39.49
Stock Price
28,035.00
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 595.82B, an increase of 12,392.78%. That is a compound annual growth rate of 22.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 592.32B | -6.29% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | 334.90B | 20.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.67T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 995.21B |
| Zydus Lifesciences | 923.82B |
| Mankind Pharma | 871.51B |
| Aurobindo Pharma | 692.90B |
| Alkem Laboratories | 672.97B |